Turnstone Biologics stock is down on Thursday as TSBX investors react to the company missing estimates for Q2.

The post Why Is Turnstone Biologics (TSBX) Stock Down 38% Today? appeared first on InvestorPlace.

SciSparc stock is up on Thursday with heavy trading of SPRC shares after it provided an update on its merger with AutoMax.

The post Why Is SciSparc (SPRC) Stock Up 94% Today? appeared first on InvestorPlace.

Conduit Pharmaceuticals stock is up on Wednesday alongside heavy trading following an invest update on CDT shares.

The post Why Is Conduit Pharmaceuticals (CDT) Stock Up 12% Today? appeared first on InvestorPlace.

TC BioPharm stock is down on Wednesday after the company priced shares of TCBP in a registered direct offering.

The post Why Is TC BioPharm (TCBP) Stock Down 46% Today? appeared first on InvestorPlace.

Viracta Therapeutics stock is up on Wednesday alongside as VIRX investors react to its most recent earnings report and business updates.

The post Why Is Viracta Therapeutics (VIRX) Stock Up 42% Today? appeared first on InvestorPlace.

Syros Pharmaceuticals stock is down on Tuesday as SYRS investors react to the company discontinuing enrollment for a clinical trial.

The post Why Is Syros Pharmaceuticals (SYRS) Stock Down 62% Today? appeared first on InvestorPlace.

60 Degrees Pharmaceuticals stock is up on Monday as SXTP investors react to an update on a clinical trial of SJ733.

The post Why Is 60 Degrees Pharmaceuticals (SXTP) Stock Up 29% Today? appeared first on InvestorPlace.

Revance Therapeutics stock is up on Monday as RVNC investors celebrate a $924 million merger agreement with Crown Laboratories.

The post Why Is Revance Therapeutics (RVNC) Stock Up 86% Today? appeared first on InvestorPlace.

Greenlane stock is up on Monday alongside heavy trading of GNLN stock after the company announced a new sales agreement.

The post Why Is Greenlane (GNLN) Stock Up 210% Today? appeared first on InvestorPlace.

Ainos stock is up on Monday as AIMD shareholders react to a deal that grants the company 10 new patent licenses.

The post Why Is Ainos (AIMD) Stock Up 38% Today? appeared first on InvestorPlace.

Buying low-priced stocks carries risk, but lower interest rates may lower the risk premium on these best stocks under $10.

The post The 7 Best Under $10 Stocks to Buy in August 2024 appeared first on InvestorPlace.

Iovance Biotherapeutics stock is gaining as IOVA investors react to strong Q2 earnings beats and positive guidance for 2024 and 2025.

The post Why Is Iovance Bio (IOVA) Stock Up 18% Today? appeared first on InvestorPlace.

Doximity stock is up on Friday as DOCS investors react to earnings and revenue beats alongside strong fiscal 2025 guidance.

The post Why Is Doximity (DOCS) Stock Up 30% Today? appeared first on InvestorPlace.

Gene-editing holds substantial promise for treating thousands of diseases – creating incredible opportunities for gene editing stocks.

The post 3 Gene Editing Stocks with Potential to Transform Medicine appeared first on InvestorPlace.

AN2 Therapeutics stock is down on Friday after ANTX investors learned of the company terminating its EBO-301 Phase 2/3 clinical trial.

The post Why Is AN2 Therapeutics (ANTX) Stock Down 35% Today? appeared first on InvestorPlace.

Eli Lilly's growth should accelerate now that shortages of its GLP-1 drugs are resolved, but competitors are coming.

The post LLY Stock Alert: Why Are Eli Lilly Shares Surging Today? appeared first on InvestorPlace.

Outset Medical stock is dropping hard on Thursday as OM investors react to the company's lackluster earnings report for Q2.

The post Why Is Outset Medical (OM) Stock Down 34% Today? appeared first on InvestorPlace.

Anew Medical stock is up on Thursday with heavy trading of WENA shares despite a lack of news from the biopharmaceutical company.

The post Why Is Anew Medical (WENA) Stock Up 37% Today? appeared first on InvestorPlace.

Conduit Pharmaceuticals stock is up on Thursday with heavy trading of CDT shares after the company announce a new license agreement.

The post Why Is Conduit Pharmaceuticals (CDT) Stock Up 123% Today? appeared first on InvestorPlace.

Explore the best dividend payouts from leading companies for sustainable, steady and growing income streams.

The post The 3 Best Dividend Aristocrats to Buy for Sustainable Income: August 2024 appeared first on InvestorPlace.

The biotech stocks with promising pipelines could see shares soar if drugs in late-stage trials get FDA approval.

The post 3 Biotech Stocks With Promising Drug Pipelines: August 2024 appeared first on InvestorPlace.

These biotech stocks are leading the way with groundbreaking therapies and robust fundamentals offering superb upside ahead.

The post The 3 Best Biotech Stocks to Buy in August 2024 appeared first on InvestorPlace.

Although the market may be reeling from the recent fallout, the red ink presents a viable opportunity in these biotech stocks.

The post 7 Biotech Stocks to Buy for Their Game-Changing Potential appeared first on InvestorPlace.

Aditxt stock is up on Wednesday with heavy trading of ADTX shares following a clinical proposal from a subsidiary.

The post Biotech News: Why Is Aditxt (ADTX) Stock Up 49% Today? appeared first on InvestorPlace.

Novo Nordisk stock is down on Wednesday with a Q2 revenue miss as the company disappoints NVO investors despite Wegovy demand increasing.

The post NVO Stock Alert: Why Is Novo Nordisk Down 8% Today? appeared first on InvestorPlace.

These are the best gene-editing stocks to buy as the biotechs pursue precision therapies to cure rare diseases.

The post The 3 Best Gene Editing Stocks to Buy in August 2024 appeared first on InvestorPlace.

Scorpius stock is falling hard on Wednesday after the company revealed the price and size of a public offering for SCPX shares.

The post Why Is Scorpius (SCPX) Stock Down 79% Today? appeared first on InvestorPlace.

G1 Therapeutics stock is up on Wednesday following news that Pharmacosmos Group is acquiring GTHX for $7.15 per share.

The post Why Is G1 Therapeutics (GTHX) Stock Up 66% Today? appeared first on InvestorPlace.

Zhongchao stock is up on Wednesday with heavy trading of ZCMD shares despite a lack of news from the healthcare information company.

The post Why Is Zhongchao (ZCMD) Stock Up 52% Today? appeared first on InvestorPlace.

Cathie Wood of ARK Invest fame has been in this Wall Street game for quite a while. Therefore, Cathie Wood stocks should be of interest.

The post The 3 Best Cathie Wood Stocks to Buy in August 2024 appeared first on InvestorPlace.

Sangamo Therapeutics stock is heading higher on Tuesday as SGMO investors react to a new $50 million license agreement.

The post Why Is Sangamo Therapeutics (SGMO) Stock Up 52% Today? appeared first on InvestorPlace.

Tenax Therapeutics stock is up on Tuesday after the company revealed an oversubscribed private placement for TENX shares.

The post Why Is Tenax Therapeutics (TENX) Stock Up 29% Today? appeared first on InvestorPlace.

These are three of the best genomics stocks to buy for a lucrative entry into a specialized section of the biotech industry.

The post 3 Genomics Stocks That May Transform Personalized Medicine  appeared first on InvestorPlace.

Cassava Sciences stock is down on Tuesday even as investors take note of SAVA shares alongside a couple of pieces of news.

The post Cassava Sciences News: Why Is SAVA Stock Trending Today? appeared first on InvestorPlace.

Investors should keep a watchful eye out for these three biotech stocks to sell before a potential dip damages their gains.

The post 3 Biotech Stocks to Sell in August Before They Crash & Burn appeared first on InvestorPlace.

VBI Vaccines stock is up on Tuesday as shares of VBIV continue to be volatile after the company filed for bankruptcy last week.

The post Why Is VBI Vaccines (VBIV) Stock Up 62% Today? appeared first on InvestorPlace.

It is never too early or too late to start investing, so choose these cheap stocks under $50 to start building your portfolio.

The post 3 Cheap Stocks to Buy in August for Under $50 appeared first on InvestorPlace.

There's nothing wrong with taking a chance on an up-and-coming company in a new field, but you should sell when it becomes an F-rated stock.

The post 7 F-Rated Stocks for Your August 2024 Sell List appeared first on InvestorPlace.

Investors should consider snapping up these high potential biotech stocks that could return 50% or more by 2028!

The post 3 Biotech Stocks on Track for 50% Returns (or More) by 2028 appeared first on InvestorPlace.

Figuring out the hottest biotech stocks can be as simple as looking at the most traded stocks by volume in the last 24 hours.

The post What Are the Hottest Biotech Stocks Right Now? 3 Top Picks. appeared first on InvestorPlace.

Biotech stocks are a high risk, high reward investment and these three biotechs offer significant upside potential.

The post 3 Biotech Stocks That Could Have Investors Grinning Soon appeared first on InvestorPlace.

Ginkgo Bioworks stock is falling hard on Friday as DNA investors prepare to vote on a reverse stock split later this month.

The post DNA Stock Alert: Ginkgo Bioworks Plunges on Plan for Reverse Stock Split appeared first on InvestorPlace.

23andMe stock is up on Friday as investors react to an offer from the company's founder to take it private for 40 cents per share for ME.

The post ME Stock Alert: CEO Anne Wojcicki Enters $200 Million Buyout Offer for 23andMe appeared first on InvestorPlace.

These are the blue-chip stocks to buy as they represent companies with strong fundamentals and growth acceleration possibility.

The post 7 Subdued Blue-Chip Stocks That Will Reward Patient Investors appeared first on InvestorPlace.

Up nearly 25% in today's session on a fast track designation for a key pancreatic cancer drug candidate, IMRX stock is coming into focus.

The post Why is Immuneering (IMRX) Stock Up 24% Today? appeared first on InvestorPlace.

While the Arbutus layoffs represents a major overhaul operationally, the market has responded positively to ABUS stock. Here’s why.

The post Arbutus Layoffs 2024: What to Know 91¶¶Òõ the Latest ABUS Job Cuts appeared first on InvestorPlace.

One of today's biggest market movers in the biotech space is RedHill Biuopharma, with RDHL stock up more than 75% on big news.

The post Why Is RedHill Biopharma (RDHL) Stock Up 75% Today? appeared first on InvestorPlace.

FibroGen layoffs are in the news Wednesday after the biopharmaceutical company announced plans to cut jobs after failed clinical trials.

The post FibroGen Layoffs 2024: What to Know 91¶¶Òõ the Latest FGEN Job Cuts appeared first on InvestorPlace.

There are more than 2,100 stocks under $10 from which to choose in the market. If you want to find the best, use the Portfolio Grader.

The post 7 Top Stocks Under $10: July 2024 Edition appeared first on InvestorPlace.

Macrogenics stock is down on Wednesday after MGNX investors learned that the company is discontinuing a Phase 2 clinical trial.

The post Why is Macrogenics (MGNX) Stock Down 28% Today? appeared first on InvestorPlace.